Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Cash Equivalents Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash Equivalents
$36.6m
CAGR 3-Years
-14%
CAGR 5-Years
-23%
CAGR 10-Years
4%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cash Equivalents
$4.2m
CAGR 3-Years
-40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash Equivalents
$111.3m
CAGR 3-Years
-30%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Cash Equivalents
CA$9.4m
CAGR 3-Years
39%
CAGR 5-Years
52%
CAGR 10-Years
9%
Spectral Medical Inc
TSX:EDT
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Aurinia Pharmaceuticals Inc's Cash Equivalents?
Cash Equivalents
36.6m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Cash Equivalents amounts to 36.6m USD.

What is Aurinia Pharmaceuticals Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
4%

Over the last year, the Cash Equivalents growth was -20%. The average annual Cash Equivalents growth rates for Aurinia Pharmaceuticals Inc have been -14% over the past three years , -23% over the past five years , and 4% over the past ten years .

Back to Top